Search Site
Menu
Endo Will Pay $13 Million to Settle Case Alleging Illegal Marketing Practices

Endo Pharmaceuticals recently settled a lawsuit with the state of Texas to the tune of $13.5 million, resolving allegations that the company engaged in illegal marketing practices for its drug Lidoderm.

The lawsuit claimed Endo purposefully misrepresented the approved uses, safety and efficacy of the drug when marketing it to the Texas Medicaid program. This would be a form of illegal promotion. From 2002 to 2006, Lidoderm’s only approved uses were for treatment of a shingles-related pain.

In addition, the lawsuit alleged Endo intentionally withheld findings from a series of five clinical trials that the drug was not any more effective than the placebo control for conditions such as carpal tunnel syndrome, lower back pain and neuropathic pain. Instead, the company chose to promote less-rigorous and in-depth studies to improve off-label usage.

Finally, the lawsuit alleged Endo routinely searched for doctors who were not likely to prescribe the drug for its approved uses, and shipped samples of the drug to executives as a means of pushing for preferential treatment for the drug (illegally).

Healthcare fraud a massive federal expense

Healthcare fraud has been a major focus of the federal government for several years now because of how much money it costs the United States. Studies indicate billions of dollars are lost to healthcare fraud every year, and it’s often difficult for investigators to uncover fraudulent schemes without the assistance of whistleblowers from the wrongdoing company.

If you have information about a fraudulent scheme operated by a healthcare organization for which you work, consult a skilled Dallas attorney at Kardell Law Group to learn about the whistleblower protections available to you.

Honors
Our Office
  • Dallas Office
    4514 Cole Ave
    #600
    Dallas, Texas 75205
    Phone: 214-306-8045
    Fax: 469-729-9926
Testimonials
  • "Steve Kardell was terrific in representing me in some very adversarial discussions with Citigroup and also later represented me in my testimony before the Financial Crisis Inquiry Commission."  -Richard Bowen, Citigroup Whistleblower

  • "Never thought my career would end like it did after 30 years of service. I was part of the first round of the so called reduction of force. I asked myself how can I be part of this with 30 years of seniority. How did they pick these 90 plus employees? Now, the culture of this organization made you question every decision they made. It wasn’t what you knew it’s was a culture of who you know. Nonetheless, I did not accept their severance package. I immediately starting looking for an attorney who would take on my case. After the initial call to Steve I had hope again. He was open and honest about everything and reassured me he would do his best for me, and he did. I had an awesome outcome. Thanks Steve you’re the best."  -S.S.

  • "Reaching out to Steve Kardell was the best decision I made. His ability to provide immediate insight and direction was very powerful, and a huge relief during a very stressful time period. For anyone struggling with a whistleblower situation, I would highly recommend at least speaking with Steve. After a 10 minute call with him, I had a better understanding of what I was dealing with. Even better, he gave me some immediate hope. In the end Steve did a better job than I thought was possible. Steve was able to get in contact with people in my organization, that I didn’t have access to. Because of his years of experience, he already has contacts in many organizations in Dallas. The entire situation was handled peacefully. I was impressed by his ability to “keep the peace”–rather than creating a battle with the organization. The reason I didn’t reach out to a lawyer initially, was because I thought it would mean an immediate end to any hope of a positive relationship with the company. Steve was able to address my concerns, and in the end I was able to continue to work for them."  -KS

FOLLOW US
Facebook Twitter Linkedin RSS Feed JD Supra